| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.4B | $20.1B | $19.5B | $18.0B | $17.4B | $4.3B | $4.0B | $3.8B |
| Cost of Revenue | $8.1B | $7.9B | $8.1B | $7.7B | $7.0B | $6.5B | $6.4B | $6.3B |
| Gross Profit | $12.3B | $12.2B | $11.3B | $10.2B | $10.4B | $2.6B | $2.4B | $2.3B |
| R&D Expense | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B |
| SG&A Expense | $7.9B | $7.7B | $7.2B | $6.6B | $6.4B | $6.0B | $5.6B | $5.4B |
| Operating Income | $3.3B | $4.3B | $4.0B | $2.9B | $3.3B | $3.9B | $3.6B | $3.7B |
| Net Income | $2.1B | $2.9B | $2.3B | $1.8B | $2.2B | $0.6B | $0.6B | $0.6B |
| EPS (Basic) | $2.64 | $3.53 | $2.78 | $2.13 | $2.56 | $0.76 | $0.75 | $0.70 |
| EPS (Diluted) | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $0.75 | $0.75 | $0.70 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.3B | $16.0B | $16.4B | $15.7B | $15.0B | $15.9B | $15.0B | $12.2B |
| Current Assets | $5.7B | $5.3B | $5.3B | $5.1B | $4.4B | $4.3B | $4.2B | $3.8B |
| Cash & Equivalents | $1.3B | $1.1B | $1.0B | $0.8B | $0.8B | $0.9B | $0.9B | $0.7B |
| Total Liabilities | $16.0B | $15.5B | $15.4B | $14.9B | $14.1B | $14.8B | $14.5B | $12.0B |
| Current Liabilities | $6.9B | $5.8B | $4.7B | $4.0B | $4.1B | $4.4B | $4.0B | $3.3B |
| Stockholders' Equity | $0.1B | $0.2B | $0.6B | $0.4B | $0.6B | $0.7B | $0.1B | $-0.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.2B | $4.1B | $3.7B | $2.6B | $3.3B | $3.7B | $3.1B | $3.1B |
| Investing Cash Flow | $-0.8B | $-0.5B | $-0.7B | $-1.6B | $-0.6B | $-0.8B | $-2.1B | $-1.2B |
| Capital Expenditures | — | — | — | $0.7B | $0.6B | $0.4B | $0.3B | $0.4B |
| Financing Cash Flow | $-3.3B | $-3.4B | $-2.8B | $-1.0B | $-2.8B | $-2.9B | $-0.9B | $-2.7B |